Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanmuga HospitalBOM:544365 +14.03%21 EBITDA Margin % is 18.70% as of Mar. 2026, which is 1% below its 10-year median of 18.88. GuruFocus rates BOM:544365 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Shanmuga Hospital ranks better than 71.75% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shanmuga Hospital's EBITDA for the
six
months ended in Mar. 2026 was ₹42.7 Mil. Shanmuga Hospital's Revenue for the
six
months ended in Mar. 2026 was ₹228.2 Mil. Therefore, Shanmuga Hospital's EBITDA margin for the quarter that ended in Mar. 2026 was 18.70%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shanmuga Hospital EBITDA Margin % Related Terms
Shanmuga Hospital EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Shanmuga Hospital's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544365 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Shanmuga Hospital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanmuga Hospital EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shanmuga Hospital's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shanmuga Hospital's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanmuga Hospital (BOM:544365) has a EBITDA Margin % of 18.70% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanmuga Hospital and its competitors. This is near median its historical median of 18.88. Over the past decade, Shanmuga Hospital's EBITDA Margin % has ranged from 17.70 to 21.98. According to the industry distribution chart, Shanmuga Hospital ranks #187 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 28.2%.
Is Shanmuga Hospital's EBITDA Margin % too high?
Shanmuga Hospital's current EBITDA Margin % of 18.70% is near median its 10-year median of 18.88. Over the past 10 years, this metric has ranged from a low of 17.70 to a high of 21.98. The Healthcare Providers & Services industry median EBITDA Margin % is 10.11. Shanmuga Hospital's value of 18.70% is 85% above this industry median. Based on the distribution chart, Shanmuga Hospital ranks #187 out of 662 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shanmuga Hospital has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Shanmuga Hospital's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shanmuga Hospital ranks #187 out of 662 companies for EBITDA Margin %. This puts Shanmuga Hospital in the upper half of its industry. The industry median EBITDA Margin % is 10.11. Shanmuga Hospital's value of 18.70% is 85% above this benchmark. Historically, Shanmuga Hospital's own EBITDA Margin % has ranged from 17.70 to 21.98 over the past decade. While the company's 10-year median is 18.88 vs. the industry median of 10.11, Shanmuga Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.11, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanmuga Hospital's current EBITDA Margin % of 18.70% is 85% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanmuga Hospital and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanmuga Hospital's current EBITDA Margin % is 18.70%, which is near median its own 10-year median of 18.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanmuga Hospital stock overvalued right now?
Shanmuga Hospital (BOM:544365) has a current EBITDA Margin % of 18.70%. The current EBITDA Margin % is 18.70%, which is near median its 10-year median of 18.88 and 85% above the Healthcare Providers & Services industry median of 10.11. Shanmuga Hospital's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shanmuga Hospital (BOM:544365), the current EBITDA Margin % is 18.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanmuga Hospital Ltd is a Multispecialty Hospital. It is Equipped with developed healthcare technology and has an approximately 151-bed capacity, it addresses the community's medical needs, serving patients from nearby regions. The hospital is committed to high-quality healthcare services, including prevention, treatment, and rehabilitation. Its medical facility encompasses an Oncology Unit, High Dependency Unit, Emergency Department, Outpatient Consultation Services, Cardiac Care Unit, Intensive Care Unit, Neonatal Intensive Care Unit, Labour Room, Endoscopy Room, Neurosurgery Unit, and Cardiac Unit. The Diagnostic Centre features developed laboratory and imaging technologies such as X-ray, Ultrasound, Computed Tomography scan, Magnetic Resonance Imaging and modular operational theatres.
21GF Score
Get the complete analysis for BOM:544365
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544365 has been successfully added to your 
